Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract.
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2015
At a glance
- Drugs Vinflunine (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms JASiMA
- Sponsors Pierre Fabre
- 13 Oct 2015 Status changed from recruiting to completed as reported by European Clinical Trials database.
- 02 Jun 2012 Actual initiation date (29 Aug 2011) and additional trial location (Italy) added as reported by European Clinical Trials Database.
- 13 Oct 2011 New trial record